Adherence to the Mediterranean dietary pattern in relation to glioma: A case–control study. Issue 1 (January 2021)

• Record Type: Journal Article
• Authors: Mousavi, Seyed Mohammad; Shayanfar, Mehdi; Rigi, Somaye; Mohammad-Shirazi, Minoo; Sharifi, Giuve; Esmaillzadeh, Ahmad
• Is Part Of: Clinical nutrition. Volume 40:Issue 1(2021)
• Page Start: 313
• Page End: 319
• Publication Date: 2021-01
• Subjects: Mediterranean -- Diet -- MD -- Glioma -- Cancer -- Brain tumor; Critically ill -- Nutrition -- Periodicals; Diet therapy -- Periodicals; Parenteral feeding -- Periodicals; Enteral feeding -- Periodicals; Enteral Nutrition -- Periodicals; Parenteral Nutrition -- Periodicals; Metabolism -- Periodicals; Diétothérapie -- Périodiques; Alimentation parentérale -- Périodiques; Alimentation entérale -- Périodiques; Nutrition -- Périodiques; Diet therapy; Enteral feeding; Nutrition; Parenteral feeding; Electronic journals; Periodicals; Electronic journals; 615.854
• DOI: 10.1016/j.clnu.2020.05.022
• Languages: English
• ISSNs: 0261-5614

Abstract

Summary: Background: Although Mediterranean diet (MD) was associated with a lower risk of mortality and cancer, no data are available investigating the association between adherence to the MD and risk of glioma. Methods: In this case–control study, we enrolled a total of 128 newly diagnosed patients with glioma, confirmed by pathological assessment, and 256 hospital-based controls from 2009 to 2011 in Tehran, Iran. A valid and reliable Block-format food frequency questionnaire (FFQ) was used to assess dietary intakes. Adherence to the MD was examined using the scoring method suggested by Trichopoulou et al. Logistic regression was used to examine the associations of interest. Results: After controlling for age, sex, and energy intake, participants in the highest tertile of MD score had not significantly lower odds of glioma than those in the lowest tertile (OR: 0.58, 95% CI: 0.32–1.03, Ptrend = 0.06). However, after taking other potential confounders into account, individuals with the greatest adherence to the MD score were 74% less likely to have glioma than those with the lowest adherence (OR: 0.26, 95% CI: 0.12–0.55, Ptrend < 0.001). Additional adjustments for dietary intakes and BMI did not significantly alter this association (OR: 0.36, 95% CI: 0.16–0.78, Ptrend = 0.009; OR: 0.36, 95% CI: 0.16–0.78, Ptrend = 0.01, respectively). Conclusion: We found that adherence to the MD was associated with a lower likelihood of having glioma. Prospective cohort studies are needed to further examine these findings.